ArrowMark Partners
Signal active
Investment Firm
Overview
ArrowMark Partners is an SEC-registered investment adviser. It aims to provide consistent, asymmetric, non-correlated, risk-adjusted returns by utilizing fundamental research across the capital structure. They are committed to compounding wealth by providing one-of-a-kind, client-driven, and absolute return solutions.
Highlights
Founded
2007
Industry
Financial Services
Employees
101-250
Investment
74
Lead Investment
10
Exits
33
Stages
Late Stage Venture, Early Stage Venture
Investor Type
Private Equity Firm
Location
United States, North America
Contact Information
Social
Profile Resume
ArrowMark Partners, established in 2007 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Biotechnology, Energy, Solar, Clean Energy, Financial Services, Finance, Consulting, Advice, Venture Capital, Health Care. The organization boasts a portfolio of 74 investments, with an average round size of $144.2M and 33 successful exits. Their recent investments include Sapphire Energy, Cascade Investment, ARCH Venture Partners, Venrock, Wellcome Trust. The highest investment round they participated in was $1349.2B. Among their most notable exits are Sapphire Energy and Cascade Investment. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
ArrowMark Partners has made 74 investments. Their most recent investment was on Jun 25, 2024, when Frontier Medicines raised $20.0M.
ArrowMark Partners has made 19 diversity investments. Their most recent diversity investment was on Aug 30, 2023, when Beta Bionics raised $100.0M.
investments
74
Diversity investments
19
Lead investments
10
Number of exits
33
Investments
74
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 18, 2024 | SmartLabs | Biotechnology | 48.0M |
| Feb 15, 2024 | Freenome | Biotechnology | 254.0M |
| May 07, 2024 | Zenas BioPharma | Health Care | 200.0M |
| Jun 25, 2024 | Frontier Medicines | Biotechnology | 20.0M |
Exits
33
Funding Timeline
Funding rounds
74
Investors
0
Funds
1
Funding Rounds
74
ArrowMark Partners has raised 74 rounds. Their latest funding was raised on Jun 25, 2024 from a Series C - Frontier Medicines round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 18, 2024 | Series C - SmartLabs | - | 48.0M | - |
| Feb 15, 2024 | Venture Round - Freenome | - | 254.0M | - |
| May 07, 2024 | Series C - Zenas BioPharma | - | 200.0M | - |
| Jun 25, 2024 | Series C - Frontier Medicines | - | 20.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.